(0) / view cart / checkout  
  Company Profiles
  Country Analyses
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
Aerospace, Defense
Business Services
Company Reports
Consumer Goods
Energy, Environment
Food & Beverages
Medical Devices
Sales & Marketing
Travel, Entertainment
Home > In Vitro Diagnostics Molecular Diagnostics >  Global Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

Global Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

Complete report $19,500.  DataPack (test volumes, sales forecasts, supplier shares) $12,500.   The report is available by country, section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. 

This new seven-country study from Venture Planning Group contains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. 

Report Highlights

- Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers.


The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry.  The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.  The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.  Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK

Worldwide Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components.

- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.

- A comprehensive analysis of the sequencing market by country and laboratory segment.
- Detailed market segmentation analysis, including review of the market dynamics, trends,
  structure, size, growth and major suppliers by country.

Product/Technology Review

- Comparison of leading infectious disease molecular diagnostic analyzers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
  trends in testing automation and over target/signal amplification methods.

- Worldwide listings of companies, universities and research centers developing new molecular
   diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, collaborative arrangements and
  new technologies/products in R&D.
   - Abbott
   - Affymetrix
   - Agilent Technologies
   - Applied Gene Technologies
   - Arca/Nuvelo
   - Beckman Coulter/Danaher
   - Becton Dickinson
   - Biokit
   - BioMerieux
   - Bio-Rad
   - Biotest
   - Caliper
   - Cepheid
   - Decode
   - Diadexus
   - Eiken
   - Enzo
   - Exact Sciences
   - Fujirebio/Innogenetics
   - Grifols
   - Hologic/Gen-Probe
   - Illumina
   - Kreatech
   - Li-Cor Biosciences
   - Life Technologies/Thermo Fisher
   - Monogram Biosciences
   - Myriad Genetics
   - Nanogen/Elitech
   - Orchid CellMark
   - Ortho-Clinical Diagnostics
   - Proteome Sciences
   - Qiagen              
   - Roche
   - Scienion
   - Sequenom
   - Shimadzu
   - Siemens
   - Sierra Molecular
   - Takara Bio
   - Tecan Group

- Comprehensive listings of companies developing and marketing infectious disease molecular
  Diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal
  during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Contains 775 pages and 73 tables

To order sections of this report, contact Client Services

Local PDF: $19500.00
Other Formats: Global PDF, DataPack
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X